Is FA a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Sterling integration and synergies, with revenue (fy2025) at ~$1.57B. The bear case rests on revenue is directly tied to hiring volumes, so a weakening labor market or slower base growth pressures results. Analysts covering it are spread from $17.00 to $24.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Revenue is directly tied to hiring volumes, so a weakening labor market or slower base growth pressures results. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $17.00, -20.7% from the $21.43 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Sterling integration and synergies. The Sterling acquisition roughly doubled First Advantage's revenue and made it the clear scale leader in independent screening. The most optimistic analyst target on FA is $24.00, +12.0% from the $21.43 price. That figure is only reachable if this thesis works close to its best case.

Revenue is directly tied to hiring volumes, so a weakening labor market or slower base growth pressures results. Net leverage near 4x amplifies both interest expense and downside if EBITDA disappoints, and integration missteps could erode expected synergies. The screening industry is heavily regulated under the Fair Credit Reporting Act and state laws, exposing the company to litigation and compliance costs. Competition from Checkr, HireRight, Accurate Background, and newer identity-verification entrants can pressure pricing. Customer concentration in cyclical verticals adds volatility. The most pessimistic published target is $17.00, -20.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

First Advantage Corporation provides background checks, identity verification, drug and health screening, and compliance solutions used by employers to vet and onboard workers.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Sterling integration and synergies) stalling in the reported numbers rather than in the narrative, the risk above (revenue is directly tied to hiring volumes, so a weakening labor market or slower base growth pressures results) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

First Advantage provides employment background checks, identity verification, drug and health screening, and compliance solutions. Employers use its services to vet and onboard workers, and the company serves roughly 80,000 organizations worldwide as of 2026.

First Advantage trades on the Nasdaq under the ticker FA. It is a US-listed operating company headquartered in the United States, not a foreign or over-the-counter listing.

FY2025 revenue rose about 83 percent to roughly $1.57 billion, driven mainly by the acquisition of Sterling Check for about $2.2 billion. That deal combined the two largest independent screeners; organic growth is much lower, in the mid-single digits.